{
    "organizations": [],
    "uuid": "9aaebb545bddb1b08e144c6294b135f7656dfc83",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-hemispherx-biopharma-says-new-deve/brief-hemispherx-biopharma-says-new-development-to-provide-consistent-enzyme-product-uninterrupted-production-of-ampligen-idUSFWN1P60FZ",
    "ord_in_thread": 0,
    "title": "BRIEF-Hemispherx Biopharma says ‍New Development to Provide Consistent Enzyme Product, Uninterrupted Production Of Ampligen",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 11 (Reuters) - Hemispherx Biopharma Inc:\n* HEMISPHERX BIOPHARMA - ‍NEW DEVELOPMENT CAN PROVIDE CONSISTENT ENZYME PRODUCT,UNINTERRUPTED PRODUCTION OF AMPLIGEN,IN LONG RUN,REDUCE PRODUCTION COSTS​ Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-01-11T21:38:00.000+02:00",
    "crawled": "2018-01-12T18:34:33.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "hemispherx",
        "biopharma",
        "inc",
        "hemispherx",
        "biopharma",
        "development",
        "provide",
        "consistent",
        "enzyme",
        "product",
        "uninterrupted",
        "production",
        "ampligen",
        "long",
        "run",
        "reduce",
        "production",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}